Suppr超能文献

Ovarian mass-differentiating benign from malignant. Why the International Ovarian Tumour Analysis rules should be implemented in Australasia.

作者信息

Abramowicz Jacques S, Condous George, Timmerman Dirk

机构信息

Ultrasound Services Department of Obstetrics and Gynecology University of Chicago Chicago IL USA.

Acute Gynaecology Early Pregnancy and Advanced Endosurgery Unit Sydney Medical School Nepean University of Sydney Penrith Sydney Australia.

出版信息

Australas J Ultrasound Med. 2018 Aug 22;21(3):121-124. doi: 10.1002/ajum.12108. eCollection 2018 Aug.

Abstract
摘要

相似文献

1
Ovarian mass-differentiating benign from malignant. Why the International Ovarian Tumour Analysis rules should be implemented in Australasia.
Australas J Ultrasound Med. 2018 Aug 22;21(3):121-124. doi: 10.1002/ajum.12108. eCollection 2018 Aug.
2
Ovarian mass-differentiating benign from malignant: the value of the International Ovarian Tumor Analysis ultrasound rules.
Am J Obstet Gynecol. 2017 Dec;217(6):652-660. doi: 10.1016/j.ajog.2017.07.019. Epub 2017 Jul 20.
4
IOTA simple rules in differentiating between benign and malignant ovarian tumors.
Asian Pac J Cancer Prev. 2014;15(13):5123-6. doi: 10.7314/apjcp.2014.15.13.5123.
6
Evaluation of IOTA Simple Ultrasound Rules to Distinguish Benign and Malignant Ovarian Tumours.
J Clin Diagn Res. 2017 Aug;11(8):TC06-TC09. doi: 10.7860/JCDR/2017/26790.10353. Epub 2017 Aug 1.
7
Subjective assessment versus ultrasound models to diagnose ovarian cancer: A systematic review and meta-analysis.
Eur J Cancer. 2016 May;58:17-29. doi: 10.1016/j.ejca.2016.01.007. Epub 2016 Feb 27.
10
Is it time to implement the International Ovarian Tumour Analysis rules in Australasia?
Australas J Ultrasound Med. 2017 May 23;20(2):55-57. doi: 10.1002/ajum.12051. eCollection 2017 May.

引用本文的文献

2
Intraoperative Diagnosis: Imprint Cytology and Frozen Section in Ovarian Tumor, Averting Additional Surgery.
J Pharm Bioallied Sci. 2024 Dec;16(Suppl 4):S4185-S4188. doi: 10.4103/jpbs.jpbs_1409_24. Epub 2024 Dec 5.
3
A Comprehensive Review of Screening Methods for Ovarian Masses: Towards Earlier Detection.
Cureus. 2023 Nov 8;15(11):e48534. doi: 10.7759/cureus.48534. eCollection 2023 Nov.

本文引用的文献

1
Is There a Future for Ovarian Cancer Screening?
JAMA Intern Med. 2018 May 1;178(5):611-612. doi: 10.1001/jamainternmed.2018.0591.
2
Ovarian mass-differentiating benign from malignant: the value of the International Ovarian Tumor Analysis ultrasound rules.
Am J Obstet Gynecol. 2017 Dec;217(6):652-660. doi: 10.1016/j.ajog.2017.07.019. Epub 2017 Jul 20.
3
First International Consensus Report on Adnexal Masses: Management Recommendations.
J Ultrasound Med. 2017 May;36(5):849-863. doi: 10.1002/jum.14197. Epub 2017 Mar 7.
5
Evaluating the risk of ovarian cancer before surgery using the ADNEX model: a multicentre external validation study.
Br J Cancer. 2016 Aug 23;115(5):542-8. doi: 10.1038/bjc.2016.227. Epub 2016 Aug 2.
6
Performance of the IOTA ADNEX model in preoperative discrimination of adnexal masses in a gynecological oncology center.
Ultrasound Obstet Gynecol. 2017 Jun;49(6):778-783. doi: 10.1002/uog.15963. Epub 2017 Apr 12.
7
Evaluation and Management of Ultrasonographically Detected Ovarian Tumors in Asymptomatic Women.
Obstet Gynecol. 2016 May;127(5):848-858. doi: 10.1097/AOG.0000000000001384.
8
The Value of Ultrasound Monitoring of Adnexal Masses for Early Detection of Ovarian Cancer.
Front Oncol. 2016 Feb 10;6:25. doi: 10.3389/fonc.2016.00025. eCollection 2016.
9
Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group.
Am J Obstet Gynecol. 2016 Apr;214(4):424-437. doi: 10.1016/j.ajog.2016.01.007. Epub 2016 Jan 19.
10
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Lancet. 2016 Mar 5;387(10022):945-956. doi: 10.1016/S0140-6736(15)01224-6. Epub 2015 Dec 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验